We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

63 hedge funds and large institutions have $28.6M invested in T2 Biosystems, Inc in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $260K | Put options by funds: $171K

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 7163 (-8)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

47% less capital invested

Capital invested by funds: $53.8M → $28.6M (-$25.3M)

Holders
63
Holders Change
-8
Holders Change %
-11.27%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
15
Reduced
13
Closed
20
Calls
$260K
Puts
$171K
Net Calls
+$89K
Net Calls Change
+$284K

TTOO Hedge Fund Activity: Q2 2019 in Review

63 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2019, worth a combined $28.6M — down 47% from $53.8M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of TTOO and 15 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 15 added.

The largest buyer was JP Morgan Chase, adding an estimated $1.69M. The largest seller was Senvest Management, cutting an estimated $3.91M.

  • 63 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2019, down from 71 in Q1 2019.
  • Funds reported $28.6M of T2 Biosystems, Inc stock for Q2 2019, down 47% quarter-over-quarter.
  • 15 funds opened new T2 Biosystems, Inc positions in Q2 2019 and 20 closed out, a net change of -5 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2019 was JP Morgan Chase, an estimated $1.69M added.
  • The largest T2 Biosystems, Inc seller in Q2 2019 was Senvest Management, an estimated $3.91M sold.

Based on aggregated 13F filings for Q2 2019.